南财智讯1月30日电，华骐环保发布年度业绩预告，预计2025年全年归属于上市公司股东的净利润 为-4,000万元—-2,500万元；预计2025年全年归属于上市公司股东的扣除非经常性损益的净利润为-4,200 万元—-2,700万元。业绩变动原因说明：1、报告期内，公司受到部分客户结算延迟与项目回款周期延 长等因素影响，基于审慎原则，相应计提了较多信用减值损失，对当期利润构成主要影响。2、报告期 内，公司持续推进业务结构优化与产品矩阵升级，带动营业收入与毛利额同步提升。通过不断加强成本 管控、提升运营效率，整体经营态势逐步改善，亏损幅度较上年同期收窄。3、预计本报告期内公司的 非经常性损益对净利润的影响金额约150万元。 ...

华骐环保公告，预计2025年度净利润为负值，预计净利润区间为-4000万元至-2500万元。预计扣除非经 常性损益后的净利润区间为-4200万元至-2700万元。报告期内，公司受到部分客户结算延迟与项目回款 周期延长等因素影响，基于审慎原则，相应计提了较多信用减值损失，对当期利润构成主要影响。 ...

证券代码：300929 证券简称：华骐环保 公告编号：2026-003 安徽华骐环保科技股份有限公司 二、与会计师事务所沟通情况 本次业绩预告未经注册会计师审计，安徽华骐环保科技股份有限公司（以 下简称"公司"）已就业绩预告有关事项与年报审计会计师事务所进行了预沟 通，公司与会计师事务所在业绩预告方面不存在分歧情况。 三、业绩变动原因说明 2025 年年度业绩预告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整， 没有虚假记载、误导性陈述或重大遗漏。 一、本期业绩预计情况 1、业绩预告期间：2025 年 1 月 1 日至 2025 年 12 月 31 日 2、业绩预告情况：预计净利润为负值 （1）以区间数进行业绩预告的 单位：万元 | 项 | 目 | 本报告期 | | | 上年同期 | | --- | --- | --- | --- | --- | --- | | 归属于上市公司 股东的净利润 | | -4,000 | ～ | -2,500 | -4,173.16 | | 扣除非经常性损 益后的净利润 | | -4,200 | ～ | -2,700 | -4,236.71 | 安徽华骐环保科技股份有 ...

Core Viewpoint - Huaji Environmental Protection announced that its subsidiary, Anhui Yingtelun Intelligent Control Co., Ltd. (referred to as "Yingtelun"), has received the "High-tech Enterprise Certificate" from the Anhui Provincial Department of Industry and Information Technology, Anhui Provincial Department of Finance, and the State Taxation Administration of Anhui Province, which is valid for three years [2] Group 1 - The certificate number issued to Yingtelun is GR202534001999, with an issuance date of October 28, 2025 [2]

Core Viewpoint - Huaji Environmental (300929.SZ) announced that its subsidiary, Anhui Yingtelun Intelligent Control Co., Ltd. (referred to as "Yingtelun"), has recently received the "High-tech Enterprise Certificate" issued by the Anhui Provincial Department of Industry and Information Technology, Anhui Provincial Department of Finance, and the State Taxation Administration of Anhui Province [1] Group 1 - The certificate number is GR202534001999, and it was issued on October 28, 2025, with a validity period of three years [1]

安徽华骐环保科技股份有限公司（以下简称"公司"）控股子公司安徽英 特伦智控股份有限公司（以下简称"英特伦"）于近日收到安徽省工业和信息 化厅、安徽省财政厅、国家税务总局安徽省税务局联合颁发的《高新技术企业 证书》，证书编号为 GR202534001999，发证日期为 2025 年 10 月 28 日，有效 期三年。 根据《中华人民共和国企业所得税法》及国家对高新技术企业的相关税收 政策等相关规定，英特伦自本次获得高新技术企业证书后连续三年可享受高新 技术企业的相关税收优惠政策。 本次获得高新技术企业证书不会对公司当期经营业绩产生重大影响，敬请 广大投资者注意投资风险。 安徽华骐环保科技股份有限公司 董事会 2026 年 1 月 20 日 证券代码：300929 证券简称：华骐环保 公告编号：2026-002 安徽华骐环保科技股份有限公司 关于控股子公司获得高新技术企业证书的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整， 没有虚假记载、误导性陈述或重大遗漏。 ...

Core Insights - The medical wastewater treatment equipment market in China is expected to grow from 2.85 billion yuan in 2015 to 4.8 billion yuan by 2024, indicating a strong growth trend driven by government support and technological advancements [1][5]. Industry Overview - Medical wastewater treatment equipment is specifically designed to handle various types of wastewater generated by hospitals, which contains pathogenic microorganisms and harmful pollutants [2]. - The treatment process typically involves a combination of physical, chemical, and biological methods to ensure effective purification [2]. Industry Policies - Recent government policies have emphasized the importance of improving wastewater treatment facilities in medical institutions, mandating the construction of adequate treatment systems to prevent untreated wastewater discharge [3][4]. Industry Chain - The industry chain consists of upstream raw materials (steel, plastic, electronic components), midstream manufacturing of treatment equipment, and downstream application in medical institutions [4]. Market Competition - The medical wastewater treatment equipment market is highly competitive, with numerous domestic and international companies offering various products and solutions [6]. - Key players include companies like Anhui Huaki Environmental Technology Co., Ltd. and Tianjin Chuangye Environmental Protection Co., Ltd., which are actively involved in the development and application of treatment technologies [6][7]. Industry Development Trends - The industry is witnessing trends towards smart, efficient, and resource-oriented wastewater treatment solutions, utilizing IoT and big data for remote monitoring and management [7]. - There is a growing focus on recycling treated wastewater for non-potable uses within hospitals, contributing to cost savings and environmental sustainability [7].

截至本公告披露日，前期已披露累计非重大诉讼、仲裁事项中有 5 项案件 取得新进展，涉及金额 6,899.74 万元。其中公司及控股子公司作为原告的诉讼、 仲裁案件中有 3 项取得新进展，涉及金额约 6,851.68 万元（裁定发回重审 1 项， 已结案 1 项，二审已判决维持原判 1 项）；公司及控股子公司作为被告的诉讼、 仲裁案件中有 2 项取得新进展，涉及金额约 48.07 万元（已结案 2 项）。除上述 5 项案件取得新进展外，其他已披露案件均无重大进展。具体情况详见附件 《累计诉讼、仲裁事项进展情况统计表》。 证券代码：300929 证券简称：华骐环保 公告编号：2026-001 安徽华骐环保科技股份有限公司 关于累计非重大诉讼、仲裁进展情况的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整， 没有虚假记载、误导性陈述或重大遗漏。 安徽华骐环保科技股份有限公司（以下简称"公司"、"华骐环保"）分 别于 2025 年 4 月 23 日、2025 年 7 月 22 日和 2025 年 10 月 23 日披露了《关于 累计非重大诉讼、仲裁情况的公告》（公告编号：2025-003）、《关于累计非 ...

风险提示：市场有风险，投资需谨慎。本文为AI大模型自动发布，任何在本文出现的信息（包括但不 限于个股、评论、预测、图表、指标、理论、任何形式的表述等）均只作为参考，不构成个人投资建 议。 责任编辑：小浪快报 数据显示，中加基金旗下1只基金重仓华骐环保。中加专精特新量化选股混合发起式A（021990）三季 度持有股数80.15万股，占基金净值比例为1.76%，位居第四大重仓股。根据测算，今日浮亏损失约 11.22万元。 中加专精特新量化选股混合发起式A（021990）成立日期2024年11月12日，最新规模1.97亿。今年以来 收益59.67%，同类排名774/8085；近一年收益56.79%，同类排名749/8085；成立以来收益59.05%。 中加专精特新量化选股混合发起式A（021990）基金经理为林沐尘。 截至发稿，林沐尘累计任职时间2年250天，现任基金资产总规模9.11亿元，任职期间最佳基金回报 60.02%， 任职期间最差基金回报0.36%。 12月31日，华骐环保跌1.3%，截至发稿，报10.59元/股，成交243.34万元，换手率0.18%，总市值13.99 亿元。 资料显示，安徽华骐环保科技 ...

Core Viewpoint - The medical water treatment industry in China is experiencing a transition from rapid expansion to high-quality structural adjustment, with a shift in demand from "new equipment" to "upgrading and maintenance" driven by intelligent upgrades [1][4][8]. Market Overview - The medical water treatment industry is a sub-sector of the environmental protection industry, focusing on treating wastewater generated by medical institutions, which contains pathogenic microorganisms and hazardous pollutants [2][4]. - The market size of China's medical water treatment industry reached 11.698 billion yuan in 2023, with a year-on-year growth of 15.2%. However, it is projected to decline to 9.997 billion yuan in 2024 due to various factors [1][8]. Market Policies - The Chinese government emphasizes the development of the medical water treatment industry, incorporating medical water safety into public health strategies and issuing various policies to enhance industry standards and quality control [4][5]. Industry Structure - The industry consists of upstream sectors (wastewater treatment equipment and chemicals), midstream (project construction and facility operation), and downstream (various medical institutions) [6][8]. - The demand market is primarily composed of hospitals at different levels, with tertiary and secondary hospitals having higher standards for water treatment [6][8]. Competitive Landscape - The medical water treatment industry in China is highly competitive, with numerous participants including specialized water treatment companies, environmental engineering firms, and medical equipment manufacturers [9][10]. - Key players include Anhui Huaki Environmental Protection Technology Co., Ltd., Beijing Qingshuiyuan Technology Co., Ltd., and others, with a focus on advanced technologies and customized solutions for medical wastewater treatment [10][12]. Development Trends - Future technological advancements in the medical water treatment industry will focus on handling special pollutants and enhancing purification efficiency, with innovations in membrane materials and advanced oxidation processes [13][14]. - The industry is expected to move towards low-carbon development, with increased application of energy-saving technologies and a focus on energy consumption control and carbon emission management [14].